Samrat Pharmachem shareholding pattern
SAMRATPH
205.9
1.95 (0.96%)Last updated on 1 Feb, 2026 | 15:29 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Summary
For Year 2025-26, Samrat Pharmachem reports the following shareholding: Total Promoters at 49.09%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 3.24%, and Retail at 47.67%. This breakdown provides a quick snapshot of ownership distribution for Samrat Pharmachem in 2025-26.
Samrat Pharmachem FAQs
As of 02-2026, the promoter shareholding in Samrat Pharmachem stands at 49.09% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Samrat Pharmachem is 0% and 3.24% respectively.
The retail shareholding of the Samrat Pharmachem is 47.67%.
Changes in shareholding patterns of Samrat Pharmachem can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Samrat Pharmachem are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
